Minimal Residual Disease in Neovascular Age-Related Macular Degeneration-Reference-Cited by-同舟云学术

Minimal Residual Disease in Neovascular Age-Related Macular Degeneration

Published:2021-04-14 Issue:06 Volume:238 Page:700-702
ISSN:0023-2165
Container-title:Klinische Monatsblätter für Augenheilkunde
language:de
Short-container-title:Klin Monbl Augenheilkd

Author:

Siedlecki Jakob¹^ORCID,Pulido Jose²³,Priglinger Siegfried¹

Affiliation:

1. Augenklinik der LMU, Klinikum der Universität München, München, Germany

2. Department of Translational Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania, United States

3. Ophthalmology and Molecular Medicine, Mayo Clinic, Rochester, MN (Minnesota), United States

Abstract

AbstractWith the advent of long-acting anti-vascular endothelial growth factor substances, “healing of AMD (age-related macular degeneration)” might be easily assumed due to prolonged treatment intervals. Adoption of the oncological concept of minimal residual disease for quiescent choroidal neovascularization (CNV) lesions might enhance the importance of continued monitoring, and spur research into the core of the disease, i.e., CNV biology.

Publisher

Georg Thieme Verlag KG

Subject

Ophthalmology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-1333-3522.pdf

Reference15 articles.

1. Targeting minimal residual disease: a path to cure?;M R Luskin;Nat Rev Cancer,2018

2. Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?;E Paietta;Bone Marrow Transplant,2002

3. The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal Lymphoma;A W Stacey;Retina,2020

4. Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy;M L Gantner;N Engl J Med,2019

5. Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naive Quiescent Choroidal Neovascularization;A Carnevali;Am J Ophthalmol,2016